Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

H.C. Wainwright BioConnect 2021 Conference
 Monday, January 11, 2021
 6:00am EST